The present results showed that the oxidative damage biomarker (MDA) level was increased and the antioxidant capacity (SOD and GSH) was significantly decreased in the COVID-19 ARDS group compared with the non-ARDS group (Fig. 3). The gene discussed is SOD1; the disease is acute respiratory distress syndrome.